97 related articles for article (PubMed ID: 30679798)
21. [Correlation of antitumor drug sensitivity between marrow mesenchymal stem cells (MSCs) and hepatocarcinoma cells in rats].
Zhou SL; Li P; Cao MM; Zhang JR
Ai Zheng; 2006 Aug; 25(8):979-82. PubMed ID: 16965678
[TBL] [Abstract][Full Text] [Related]
22. 5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story.
Coral S; Sigalotti L; Covre A; Nicolay HJ; Natali PG; Maio M
Cancer Res; 2007 Mar; 67(6):2900-1; author reply 2901-2. PubMed ID: 17363616
[No Abstract] [Full Text] [Related]
23. Panobinostat inhibits the proliferation of CD34
Kurata T; Matsuda K; Hirabayashi K; Shigemura T; Sakashita K; Nakahata T; Koike K
Pediatr Blood Cancer; 2018 Nov; 65(11):e27261. PubMed ID: 30014555
[TBL] [Abstract][Full Text] [Related]
24. Drug Receives New Indication for Juvenile Myelomonocytic Leukemia.
Aschenbrenner DS
Am J Nurs; 2022 Sep; 122(9):25. PubMed ID: 36005792
[TBL] [Abstract][Full Text] [Related]
25. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
Dong L; Yu WM; Zheng H; Loh ML; Bunting ST; Pauly M; Huang G; Zhou M; Broxmeyer HE; Scadden DT; Qu CK
Nature; 2016 Nov; 539(7628):304-308. PubMed ID: 27783593
[TBL] [Abstract][Full Text] [Related]
26. Juvenile myelomonocytic leukemia with less aggressive clinical course and KRAS mutation.
Imamura M; Imai C; Takachi T; Nemoto T; Tanaka A; Uchiyama M
Pediatr Blood Cancer; 2008 Oct; 51(4):569. PubMed ID: 18561174
[No Abstract] [Full Text] [Related]
27. Involvement of mesenchymal stem cells in cancer progression and metastases.
Chang AI; Schwertschkow AH; Nolta JA; Wu J
Curr Cancer Drug Targets; 2015; 15(2):88-98. PubMed ID: 25619387
[TBL] [Abstract][Full Text] [Related]
28. [Juvenile myelomonocytic leukemia: A three-case series].
Ghariani I; Jmili-Braham N; Regaieg H; Achour B; Ben Youssef Y; Sendi H; Bakir L; Kortas M
Arch Pediatr; 2016 Dec; 23(12):1264-1269. PubMed ID: 27789175
[TBL] [Abstract][Full Text] [Related]
29. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
[TBL] [Abstract][Full Text] [Related]
30. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
[TBL] [Abstract][Full Text] [Related]
31. Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia.
Kwon HY; Bajaj J; Ito T; Blevins A; Konuma T; Weeks J; Lytle NK; Koechlein CS; Rizzieri D; Chuah C; Oehler VG; Sasik R; Hardiman G; Reya T
Cell Stem Cell; 2015 Aug; 17(2):152-164. PubMed ID: 26212080
[TBL] [Abstract][Full Text] [Related]
32. JMML patient-derived iPSCs induce new hypotheses.
Chan RJ; Yoder MC
Blood; 2013 Jun; 121(24):4815-7. PubMed ID: 23766458
[TBL] [Abstract][Full Text] [Related]
33. The cancer stem cell hypothesis: a guide to potential molecular targets.
Allegra A; Alonci A; Penna G; Innao V; Gerace D; Rotondo F; Musolino C
Cancer Invest; 2014 Nov; 32(9):470-95. PubMed ID: 25254602
[TBL] [Abstract][Full Text] [Related]
34. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells.
Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK
Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170
[TBL] [Abstract][Full Text] [Related]
35. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness.
Xue J; Zhu Y; Sun Z; Ji R; Zhang X; Xu W; Yuan X; Zhang B; Yan Y; Yin L; Xu H; Zhang L; Zhu W; Qian H
BMC Cancer; 2015 Oct; 15():793. PubMed ID: 26498753
[TBL] [Abstract][Full Text] [Related]
36. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
37. (64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.
Yoshii Y; Furukawa T; Matsumoto H; Yoshimoto M; Kiyono Y; Zhang MR; Fujibayashi Y; Saga T
Cancer Lett; 2016 Jun; 376(1):74-82. PubMed ID: 26996296
[TBL] [Abstract][Full Text] [Related]
38. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
[TBL] [Abstract][Full Text] [Related]
39. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells.
Ito S; Barrett AJ; Dutra A; Pak E; Miner S; Keyvanfar K; Hensel NF; Rezvani K; Muranski P; Liu P; Larochelle A; Melenhorst JJ
Stem Cell Res; 2015 Jan; 14(1):95-104. PubMed ID: 25535865
[TBL] [Abstract][Full Text] [Related]
40. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]